1. Home
  2. MCHX vs INMB Comparison

MCHX vs INMB Comparison

Compare MCHX & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

SELL

Current Price

$1.29

Market Cap

60.3M

ML Signal

SELL

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

BUY

Current Price

$1.44

Market Cap

64.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
MCHX
INMB
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.3M
64.7M
IPO Year
2003
2018

Fundamental Metrics

Financial Performance
Metric
MCHX
INMB
Price
$1.29
$1.44
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $7.00
AVG Volume (30 Days)
27.8K
★ 269.7K
Earning Date
11-12-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 11.85
EPS
★ N/A
N/A
Revenue
★ $90,291,000.00
$50,000.00
Revenue This Year
$17.69
N/A
Revenue Next Year
$29.82
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 257.14
52 Week Low
$1.15
$1.09
52 Week High
$2.00
$2.60

Technical Indicators

Market Signals
Indicator
MCHX
INMB
Relative Strength Index (RSI) 43.60 27.46
Support Level $1.20 $1.34
Resistance Level $1.46 $1.52
Average True Range (ATR) 0.09 0.11
MACD 0.01 -0.02
Stochastic Oscillator 30.00 5.94

Price Performance

Historical Comparison
MCHX
INMB

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Share on Social Networks: